Cite

HARVARD Citation

    Miles, D. et al. (n.d.). Discovery and characterization of potent and selective AXL receptor tyrosine kinase inhibitors for cancer therapy. European journal of cancer. pp. S38-S39. [Online]. 
  
Back to record